
Radiation Oncologist @UCSDRadMed, alum of @UChicago | @Georgetown | @UICCOM | #bcsm #gyncsm #meded #globalhealth #DEIinRO
San Diego, CA
Joined August 2008
- Tweets565
- Following636
- Followers610
- Likes3.8K
Karen Tye, MD MS retweeted
Words cannot describe how profoundly sad I am to share the news of Dr. Shekinah Elmore's death this week.
Shekinah was a SPECTACULAR human with profound wisdom, an incredible generosity of spirit, & a heart of kindness that lifted us all up.
gofundme.com/f/honoring-dr-s…
Karen Tye, MD MS retweeted
Is this another site that could benefit from collaborative #radiology and #radonc target delineation?
@MichaelFarrisM1 @JPonnatapura have shown it's feasible in LA #LCSM, I look forward to testing it in #hncsm @wakeforestmed @AtriumHealthWFB
doi.org/10.1016/j.acra.2023.…
ReIGNITE: large uncertainties defining the intraprostatic tumor in conv MRI
❓ future of intraprostatic boost, PACE-B with 5a EFS 95.8% after 40Gy/5 to whole prostate
❓ high risk pts only, 84% in FLAME
@piet_ost @alison_tree @nickva1 @KerkmeijerLinda
redjournal.org/article/S0360…
Karen Tye, MD MS retweeted
From the #RedJournal, read #radonc perspectives on DEI, featuring @pre_rad @VonettaMW @ktye @IvyRadOncMD @reshmajagsi @A_CT_SimMDJD @DrMalikaSiker @GitaSuneja @NehaVapiwala @GlobalRadOnc @LiaHalaszMD @UNCRadOnc @UNC_Lineberger bit.ly/3Xd2tbv
Karen Tye, MD MS retweeted
Current Issue: Automated Patient-level Prostate Cancer Detection with Quantitative Diffusion Magnetic Resonance Imaging
buff.ly/3VLkPiv
@AllisonZhong @christinefeng @ktye @DrAsonaLui @cjkane10 @RakowPenner @TylerSbrt
#prostatecancer #MRI #openaccess #openscience
Karen Tye, MD MS retweeted
Some exciting #ROVER sessions after #ASTRO22:
- FRIDAY 11/4: 3 pm EST: Rectal Cancer: Neoadjuvant Tx Strategies
- FRIDAY 11/11: 3 pm EST @RadiumSociety ROCKET and ROVER: Out of Left Field: Exploring Alternative #radonc Career Paths
Sign up 👇
radoncvirtual.com
Karen Tye, MD MS retweeted
The Patient: Paul Hinds, now 60, is covered by United Healthcare through a COBRA plan from his former employer.
Medical Service: Two three-month Lupron Depot injections for metastatic prostate cancer.
npr.org/sections/health-shot…
1st in person #ASTRO in 3 yrs and I kicked it off with a 🔥🔥🔥 group! Fantastic international presence at our breakout session on teaching #DEIinRO to faculty and staff, thrilled to see a project 2 yrs in the making come to fruition @MalcolmMattesMD #ASTRO22
This Post is from a suspended account. Learn more
Karen Tye, MD MS retweeted
From mammograms to treatment plans, we're with you every step of the way 💗
Here at the region's ONLY NCI-designated comprehensive cancer center, our breast cancer team delivers the best care and results.
Schedule a mammogram ➡️ bit.ly/3VmGXRg
#BreastCancerAwareness
Big ups to M2 Caroline Clark @clarkalarm for presenting at @wakeforestmed 37th annual Medical Student Research Day on the impact of omitting radiation boost for breast conservation pts in the modern era of shave cavity margins here at @AtriumHealthWFB 👏🏼👏🏼👏🏼 @WakeCancer #bcsm
Karen Tye, MD MS retweeted
Excited for the #DEIinOncology programing a the upcoming @ASTRO_org #ASTRO22 Annual Meeting.
📲Mark these #DEIinRO #HEDI events now!
🎯Register for the MASTER CLASS today!
⭐️Centering on Equity: Reflecting on Unconscious Bias, Dominant Culture & Privilege
📅 Sat, 10/22 1-3 PM
Yes! For pts age 50-69, ER+ HER2- node neg Oncotype <18, BR007 is currently open and accruing at @WakeCancer @wakeradonc
HER2+ pts, we are looking to open BR008 in the Triad soon… stay tuned #NRG2022 @AtriumHealthWFB @NRGonc #bcsm
Replying to @A_CT_SimMDJD
Learned from some phenomenal speakers this am @KHigginsMD @d_golden @MontessaLee
Patient advocates are some of our most impactful teachers. Thank you for turning your experience into advocacy, reminding us about the potential of bringing pts into “the room where it happens” 👏🏼
Attending #NRG2022 in-person or virtually? Good news - our Social Media Workshop is going to be a hybrid session - and we will be recording it for future viewing. It is being held on Friday, July 22nd at 8:30am CDT. Hope to see you there! @KHigginsMD @MontessaLee @d_golden
So proud of @HadleyWalsh1 who is a terrific @wakeforestmed student and took the initiative to put together this @ARRO_org case. We hope others find our mnemonic for remembering “suitable” candidates for APBI helpful. #bcsm #meded #radonc
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
Karen Tye, MD MS retweeted
Does the timing of chemo and RT start matter for #hncsm patients treated with definitive CRT?
Our group @steberc19 @WakeRadOncRes looked at this question with our cohort (n=131) of patients treated with definitive 💉+☢️for HNSCC (mostly OP/L).
doi.org/10.1080/0284186X.202…
1/n
Karen Tye, MD MS retweeted
Congratulations to our graduates @steberc19 @AJ_Icarus @KarinaNietoMD! We’re so proud of the #radonc doctors you’ve become ☢️🧬👩🏽⚕️👨🏽⚕️
We’ll miss you! ❤️
Karen Tye, MD MS retweeted
The ARRO Equity & Inclusion Subcommittee is continuing its mentorship program for those with interests in diversity/equity/inclusion and health disparities. To become a mentor and/or mentee, join at:
docs.google.com/forms/d/e/1F…
#UIM #equity #diversity
Karen Tye, MD MS retweeted
We can't do this anymore. Firearms are the problem.
A murderer can buy a semiautomatic weapon and kill four people an hour later. I can't get Lupron approved to give a patient an hour later.
Everything is wrong and we can't do this anymore.
This Post is from an account that no longer exists. Learn more
Karen Tye, MD MS retweeted
Based on these findings and others, how would YOU prefer to review your #radonc chart rounds?
7/7
30%In-person
70%Virtual
40 votes • Final results Karen Tye, MD MS retweeted
Our recent analysis of in-person 🧑🤝🧑 versus virtual 🖥️chart rounds peer review is out in @IJROBP!
Here's a🧵to summarize our findings #Tweetorial
doi.org/10.1016/j.ijrobp.202…
1/7











































